Patients, Caregivers, and the Danger of Imaging Studies: The Four Horsemen of the Radiology Apocalypse and What Must Be Done... CME

Author Information and Disclosures

Release Date: April 23, 2008; Valid for credit through April 23, 2009

Credits Available
Physicians - maximum of 0.75 AMA PRA Category 1 Credit(s)™ for physicians

To participate in this internet activity: (1) review the target audience, learning objectives, and author disclosures; (2) study the education content; (3) take the post-test and/or complete the evaluation; (4) view/print certificate View details.

Legal Disclaimer

The material presented here does not necessarily reflect the views of Medscape or companies that support educational programming on www.medscape.com. These materials may discuss therapeutic products that have not been approved by the US Food and Drug Administration and off-label uses of approved products. A qualified healthcare professional should be consulted before using any therapeutic product discussed. Readers should verify all information and data before treating patients or employing any therapies described in this educational activity.

Copyright © 2008 Medscape.
Medscape
Learning Objectives
Upon completion of this activity, participants will be able to:
  1. Debate the potential health risks involved in the use of imaging studies such as CT scanning that deliver radiation;
  2. Detail measures that can reduce radiation risk to patients undergoing CT scans;
  3. Describe the incidence of contrast-induced nephropathy (CIN) in CT scanning and ways to limit the risk of CIN during imaging;
  4. Discuss the prevalence of nephrogenic systemic fibrosis (NSF) in enhanced MRI studies and methods to curtail risk to patients;
  5. Delineate the cardiopulmonary safety concerns related to the use of microbubble contrast agents in echocardiography.
Authors and Disclosures

Richard C. Semelka, MD
Disclosure: Richard C. Semelka, MD, has disclosed that he has been on the speakers' bureau of Berlex Imaging (manufacturer of Magnevist) more than 5 years ago, and has been an advisor and is currently on the speakers' bureau of Bracco (manufacturer of MultiHance).


Robert Chevrier
Disclosure: Robert Chevrier has disclosed no relevant financial relationships.
 
Medscape
Medscape, LLC is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Medscape, LLC designates this educational activity for a maximum of 0.75 AMA PRA Category 1 Credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

Contact This Provider

All material on this website is protected by copyright, Copyright © 1994-2008 by Medscape. This website also contains material copyrighted by 3rd parties.